Literature DB >> 9083021

The Src homology 2 (SH2) domain of SH2-containing inositol phosphatase (SHIP) is essential for tyrosine phosphorylation of SHIP, its association with Shc, and its induction of apoptosis.

L Liu1, J E Damen, M R Hughes, I Babic, F R Jirik, G Krystal.   

Abstract

In this study we have investigated the role that the Src homology 2 domain (SH2) of the 145-kDa 5-phosphatase, SH2-containing inositol phosphatase (SHIP), plays in three of the properties that have been associated with this protein following cytokine stimulation: its association with Shc, its tyrosine phosphorylation, and its inhibition of hemopoietic cell growth. In vitro studies using this SH2 domain revealed that it was capable of binding directly to the Tyr(P)317 motif of Shc with a KD of approximately 290 nM, in keeping with other specific SH2/Tyr(P) interactions. In vivo analysis revealed the SH2 and NPXpY motifs of SHIP acted together, with the Tyr(P)317 and phosphotyrosine binding (PTB) domains of Shc, respectively, to ensure a high affinity SHIP.Shc complex. Expression of cDNAs encoding hemagglutinin-tagged wild type and SH2-inactivated forms of SHIP in the murine hemopoietic cell line DA-ER revealed that wild type SHIP becomes both tyrosine-phosphorylated and associated with Shc following interleukin-3 stimulation, as expected, but the SH2-inactivated SHIPs do neither. Moreover, while the growth rates of parental DA-ER cells and cells expressing these various SHIP constructs are identical, the wild type SHIP-expressing cells die, via programmed cell death, far more rapidly than parental cells. Cells expressing SH2-inactivated SHIPs, on the other hand, show either a reduced or no effect on apoptosis. These results suggest that the SH2 domain of SHIP is required not only for the tyrosine phosphorylation of SHIP and Shc association following cytokine stimulation but also for its induction of apoptosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9083021     DOI: 10.1074/jbc.272.14.8983

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

Review 1.  Negative signaling in health and disease.

Authors:  K M Coggeshall
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Essential role for the C-terminal noncatalytic region of SHIP in FcgammaRIIB1-mediated inhibitory signaling.

Authors:  M J Aman; S F Walk; M E March; H P Su; D J Carver; K S Ravichandran
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

3.  SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival.

Authors:  Q Liu; T Sasaki; I Kozieradzki; A Wakeham; A Itie; D J Dumont; J M Penninger
Journal:  Genes Dev       Date:  1999-04-01       Impact factor: 11.361

4.  Interleukin 3-dependent survival by the Akt protein kinase.

Authors:  Z Songyang; D Baltimore; L C Cantley; D R Kaplan; T F Franke
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

5.  Recruitment and phosphorylation of SH2-containing inositol phosphatase and Shc to the B-cell Fc gamma immunoreceptor tyrosine-based inhibition motif peptide motif.

Authors:  S Tridandapani; T Kelley; M Pradhan; D Cooney; L B Justement; K M Coggeshall
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

6.  pp60c-src associates with the SH2-containing inositol-5-phosphatase SHIP1 and is involved in its tyrosine phosphorylation downstream of alphaIIbbeta3 integrin in human platelets.

Authors:  S Giuriato; S Bodin; C Erneux; R Woscholski; M Plantavid; H Chap; B Payrastre
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

7.  Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma.

Authors:  Imran A Babar; Christopher J Cheng; Carmen J Booth; Xianping Liang; Joanne B Weidhaas; W Mark Saltzman; Frank J Slack
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-08       Impact factor: 11.205

8.  SH2-containing inositol 5'-phosphatase inhibits transformation of Abelson murine leukemia virus.

Authors:  Shawn P Fessler; Naomi Rosenberg; Linda B Baughn
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

9.  Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span.

Authors:  C D Helgason; J E Damen; P Rosten; R Grewal; P Sorensen; S M Chappel; A Borowski; F Jirik; G Krystal; R K Humphries
Journal:  Genes Dev       Date:  1998-06-01       Impact factor: 11.361

10.  Targeted disruption of SHIP leads to Steel factor-induced degranulation of mast cells.

Authors:  M Huber; C D Helgason; M P Scheid; V Duronio; R K Humphries; G Krystal
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.